| Predicate |
Object |
| contentType |
Journal Article|Research Support, Non-U.S. Gov't |
| endingPage |
141 |
| issn |
0954-6111 |
| pageRange |
139-141 |
| publicationName |
Respiratory Medicine |
| startingPage |
139 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a71302725c50a93636ce1eb2c57020e3 |
| bibliographicCitation |
Yancey SW, Bradford ES, Keene ON. Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150-300 cells/μL. Respir Med. 2019 May;151():139–41. doi: 10.1016/j.rmed.2019.04.008. PMID: 31047111. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ef1143057ebed5736cbc8452308979c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_900c69ba3cacf3c7d621d86a77ba4c3d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_157037c493205100ccde1d214a35280f |
| date |
201905 |
| identifier |
https://doi.org/10.1016/j.rmed.2019.04.008
https://pubmed.ncbi.nlm.nih.gov/31047111 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7035
https://portal.issn.org/resource/ISSN/0954-6111 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150–300 cells/μL |
| discusses |
http://id.nlm.nih.gov/mesh/M0397468
http://id.nlm.nih.gov/mesh/M0028296
http://id.nlm.nih.gov/mesh/M0556300 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D007958
http://id.nlm.nih.gov/mesh/D004804Q000378
http://id.nlm.nih.gov/mesh/D061067Q000627
http://id.nlm.nih.gov/mesh/D018927Q000627
http://id.nlm.nih.gov/mesh/D001249Q000188
http://id.nlm.nih.gov/mesh/D001249Q000097 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D017326 |